Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18947885rdf:typepubmed:Citationlld:pubmed
pubmed-article:18947885lifeskim:mentionsumls-concept:C0383327lld:lifeskim
pubmed-article:18947885lifeskim:mentionsumls-concept:C2700455lld:lifeskim
pubmed-article:18947885lifeskim:mentionsumls-concept:C0031715lld:lifeskim
pubmed-article:18947885lifeskim:mentionsumls-concept:C0815000lld:lifeskim
pubmed-article:18947885lifeskim:mentionsumls-concept:C0031727lld:lifeskim
pubmed-article:18947885lifeskim:mentionsumls-concept:C0442805lld:lifeskim
pubmed-article:18947885lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:18947885lifeskim:mentionsumls-concept:C1947974lld:lifeskim
pubmed-article:18947885lifeskim:mentionsumls-concept:C1314939lld:lifeskim
pubmed-article:18947885lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:18947885lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:18947885lifeskim:mentionsumls-concept:C1720655lld:lifeskim
pubmed-article:18947885pubmed:issue1-2lld:pubmed
pubmed-article:18947885pubmed:dateCreated2008-11-25lld:pubmed
pubmed-article:18947885pubmed:abstractTextInflammatory cytokines, produced mainly by activated microglia in the brain, can enhance neuronal degeneration and the amyloid-beta-plaque production involved in Alzheimer's disease (AD). We previously demonstrated that the expression of the pro-inflammatory cytokine interleukin-18 (IL-18) colocalizes with plaques and hyperphoshorylated tau containing neurons in AD patients. Here we exposed neuron-like, differentiated SH-SY5Y neuroblastomas to IL-18 and observed that the protein levels of p35, Cdk5, GSK-3beta, and Ser15-phosphorylated p53 increased during 6 h-24 h. Tau phosphorylation and expression of cyclin G1, involved in neuronal regeneration, increased at 72 h. In vivo, over-expression of IL-18 may induce hyperphosphorylation of tau and induce cell cycle activators.lld:pubmed
pubmed-article:18947885pubmed:languageenglld:pubmed
pubmed-article:18947885pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18947885pubmed:citationSubsetIMlld:pubmed
pubmed-article:18947885pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18947885pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18947885pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18947885pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18947885pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18947885pubmed:statusMEDLINElld:pubmed
pubmed-article:18947885pubmed:monthDeclld:pubmed
pubmed-article:18947885pubmed:issn0165-5728lld:pubmed
pubmed-article:18947885pubmed:authorpubmed-author:SalminenAnter...lld:pubmed
pubmed-article:18947885pubmed:authorpubmed-author:PirttiläTuula...lld:pubmed
pubmed-article:18947885pubmed:authorpubmed-author:OjalaJohanna...lld:pubmed
pubmed-article:18947885pubmed:authorpubmed-author:SutinenElina...lld:pubmed
pubmed-article:18947885pubmed:issnTypePrintlld:pubmed
pubmed-article:18947885pubmed:day15lld:pubmed
pubmed-article:18947885pubmed:volume205lld:pubmed
pubmed-article:18947885pubmed:ownerNLMlld:pubmed
pubmed-article:18947885pubmed:authorsCompleteYlld:pubmed
pubmed-article:18947885pubmed:pagination86-93lld:pubmed
pubmed-article:18947885pubmed:meshHeadingpubmed-meshheading:18947885...lld:pubmed
pubmed-article:18947885pubmed:meshHeadingpubmed-meshheading:18947885...lld:pubmed
pubmed-article:18947885pubmed:meshHeadingpubmed-meshheading:18947885...lld:pubmed
pubmed-article:18947885pubmed:meshHeadingpubmed-meshheading:18947885...lld:pubmed
pubmed-article:18947885pubmed:meshHeadingpubmed-meshheading:18947885...lld:pubmed
pubmed-article:18947885pubmed:meshHeadingpubmed-meshheading:18947885...lld:pubmed
pubmed-article:18947885pubmed:meshHeadingpubmed-meshheading:18947885...lld:pubmed
pubmed-article:18947885pubmed:meshHeadingpubmed-meshheading:18947885...lld:pubmed
pubmed-article:18947885pubmed:meshHeadingpubmed-meshheading:18947885...lld:pubmed
pubmed-article:18947885pubmed:meshHeadingpubmed-meshheading:18947885...lld:pubmed
pubmed-article:18947885pubmed:meshHeadingpubmed-meshheading:18947885...lld:pubmed
pubmed-article:18947885pubmed:meshHeadingpubmed-meshheading:18947885...lld:pubmed
pubmed-article:18947885pubmed:year2008lld:pubmed
pubmed-article:18947885pubmed:articleTitleInterleukin-18 increases expression of kinases involved in tau phosphorylation in SH-SY5Y neuroblastoma cells.lld:pubmed
pubmed-article:18947885pubmed:affiliationUniversity of Kuopio, Institute of Clinical Medicine/Neurology, Canthia, P.O.B. 1627, FIN-70211 Kuopio, Finland. Johanna.Ojala@uku.filld:pubmed
pubmed-article:18947885pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18947885pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18947885lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18947885lld:pubmed